数据链接：
官方服务：
资源简介：
Clinical outcomes: PCI group versus CABG group.
应用场景：
创建时间：
2022-09-29
相关数据集
Overview of included RRMS phase-3 trials (n = 13).
RRF = Rate of relapse free patients after 2 years, SE = Standard error, ARR = Annualized relapse rate over 2 years, SD = Standard deviation, 2001/2005 indicates the use of the original 2001 McDonald c
Figshare2015-12-02 更新50
An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer
This observational study evaluates the efficacy and safety of capecitabine in combination with oxaliplatin in the adjuvant setting in participants with Stage III colon cancer. Data were collected from
NIAID Data Ecosystem40
Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.
Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.
Figshare2018-09-20 更新20
COR peak week 1 improvement and COR peak week 5 improvement.
Response and remission rates after 5 weeks of treatment in 40 depressed patients (sample 2) treated with either reboxetine (n = 20) or mirtazapine (n = 20) [33]. Patients are subdivided into COR peak
NIAID Data Ecosystem50
Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).
Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).
Figshare2022-11-02 更新30
